Preclinical Evaluation of the Efficacy of Human Sirpa Antibodies for B-Cell Lymphoma Immunotherapy in Humanized Mouse Models

被引:0
|
作者
Saito, Yasuyuki [1 ]
Tania, Afroj [2 ]
Komori, Satomi [2 ]
Takai, Tomoko [2 ]
Oduori, Okechi S. [2 ]
Kotani, Takenori [1 ]
Funakoshi, Yohei [3 ]
Murata, Yoji [1 ]
Yakushijin, Kimikazu [3 ]
Matsuoka, Hiroshi [4 ]
Minami, Hironobu [3 ]
Manz, Markus G. [5 ,6 ]
Matozaki, Takashi [2 ]
机构
[1] Kobe Univ, Div Mol & Cellular Signaling, Grad Sch Med, Kobe, Japan
[2] Kobe Univ, Div Biosignal Regulat, Grad Sch Med, Kobe, Japan
[3] Kobe Univ Hosp, Dept Med Oncol & Hematol, Kobe, Japan
[4] Kobe Univ Hosp, Div Bioresource Res & Dev, Kobe, Japan
[5] Univ Hosp Zurich, Dept Med Oncol & Hematol, Zurich, Switzerland
[6] Comprehens Canc Ctr Zurich, Zurich, Switzerland
关键词
D O I
10.1182/blood-2023-181926
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Biodynamic Imaging of Therapeutic Efficacy for Canine B-cell Lymphoma: Preclinical Trial Results
    Choi, H.
    Li, Z.
    Turek, J.
    Childress, M.
    Nolte, D.
    DYNAMICS AND FLUCTUATIONS IN BIOMEDICAL PHOTONICS XV, 2018, 10493
  • [22] Humanized mouse models for preclinical evaluation of novel immune cell therapies, checkpoint inhibitors, and immune cell engagers
    Stecklum, Maria
    Wulf-Goldenberg, Annika
    Brzezicha, Bernadette
    Walther, Wolfgang
    Hoffmann, Jens
    CANCER RESEARCH, 2022, 82 (12)
  • [23] Preclinical evaluation of macrophage-targeted immunotherapy in vivo using a humanized mouse model
    Saito, Yasuyuki
    Afroj, Tania
    Iida, Rie
    Komori, Satomi
    Takai, Tomoko
    Oduori, Okechi S.
    Kotani, Takenori
    Koma, Yuichiro
    Murata, Yoji
    Yokozaki, Hiroshi
    Matozaki, Takashi
    CANCER SCIENCE, 2024, 115 : 473 - 473
  • [24] Combination Benefit of Capivasertib and Venetoclax in Preclinical Models of Diffuse Large B-Cell Lymphoma
    Willis, Brandon
    Neveras, India
    Dry, Hannah
    Xu, Wendan
    Li, Yang
    Mongeon, Kevin
    Roderick, Justine
    Rosen, Alan
    Klener, Pavel, Jr.
    Lenz, Georg
    Mettetal, Jerome
    Barry, Simon
    BLOOD, 2021, 138 : 1870 - +
  • [25] Humanized mouse models for personalized preclinical testing of monoclonal antibodies targeting immune checkpoints
    Baia, Gilson S.
    Vasquez, David
    Ciznadija, Daniel
    Wilkinson, Brandy
    Sidransky, David
    Katz, Amanda
    Paz, Keren
    CANCER RESEARCH, 2014, 74 (19)
  • [26] Bispecific Antibodies for Aggressive B-Cell Lymphoma
    Bennett, Rory
    Dickinson, Michael
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S91 - S93
  • [27] PRECLINICAL EVALUATION OF A CHIMERIC AND HUMANIZED ANTI-B-CELL LYMPHOMA ANTIBODY, LL2
    SHEVITZ, J
    SHARKEY, RM
    GOLDENBERG, DM
    LEUNG, SO
    SHIH, LB
    HARAGA, LT
    SHUKLA, R
    HANSEN, HJ
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P236 - P236
  • [28] Humanized mouse models for preclinical evaluation of novel immune therapies, checkpoint inhibitors and immune cell engagers
    Stecklum, M.
    Brzezicha, B.
    Rhein, S.
    Walther, W.
    Hoffmann, J.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S12 - S12
  • [29] Preclinical Evaluation of the Oral Proteasome Inhibitor Ixazomib in Diffuse Large B-Cell Lymphoma
    Liu, Wei
    Tamayo, Archie
    Chen, Juan
    Hu, Shimin
    Ford, Richard J., Jr.
    Lan Pham
    BLOOD, 2015, 126 (23)
  • [30] Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia
    Lenk, Lennart
    Winterberg, Dorothee
    Vogiatzi, Fotini
    Laqua, Anna
    Spory, Lea
    Mayar, Ahmad
    Dietterle, Anna
    Muench, Gina
    Vokuhl, Christian
    Richter, Julia
    Polson, Andrew G.
    Schueler, Thomas
    Kahlert, Ulf D.
    Peipp, Matthias
    Valerius, Thomas
    Schrappe, Martin
    Cario, Gunnar
    Jumaa, Hassan
    Hobeika, Elias
    Brueggemann, Monika
    Alsadeq, Ameera
    Schewe, Denis M.
    HEMASPHERE, 2022, 6 (08):